InnoCare Optoelectronics (TPE:6861) Change In Receivables: NT$-60 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6861 InnoCare Optoelectronics Corp TPE:6861
75 GF Score
Price NT$186.50
GF Value NT$101.54
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is InnoCare Optoelectronics Change In Receivables?

InnoCare Optoelectronics TPE:6861 +1.91% 75 Change In Receivables is NT$-60 Mil as of Jun. 2026. GuruFocus rates TPE:6861 with a GF Score™ of 75/100 and a GF Value™ of NT$101.54 (Significantly Overvalued). The stock has 2 warning signs investors should review.

InnoCare Optoelectronics's change in receivables for the quarter that ended in Jun. 2026 was NT$123 Mil. It means InnoCare Optoelectronics's Accounts Receivable declined by NT$123 Mil from Mar. 2026 to Jun. 2026 .

InnoCare Optoelectronics's change in receivables for the fiscal year that ended in Dec. 2025 was NT$-115 Mil. It means InnoCare Optoelectronics's Accounts Receivable increased by NT$115 Mil from Dec. 2024 to Dec. 2025 .

InnoCare Optoelectronics's Accounts Receivable for the quarter that ended in Jun. 2026 was NT$750 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. InnoCare Optoelectronics's Days Sales Outstanding for the three months ended in Jun. 2026 was 90.44.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. InnoCare Optoelectronics's liquidation value for the three months ended in Jun. 2026 was NT$508 Mil.

InnoCare Optoelectronics  (TPE:6861) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

InnoCare Optoelectronics's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=750.333/757.027*91
=90.44

2. In Ben Graham's calculation of liquidation value, InnoCare Optoelectronics's accounts receivable are only considered to be worth 75% of book value:

InnoCare Optoelectronics's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=867.461-1419.855+0.75 * 750.333+0.5 * 996.124
=508

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnoCare Optoelectronics Change In Receivables Related Terms

InnoCare Optoelectronics Change In Receivables Historical Data

* Premium members only.

The historical data trend for InnoCare Optoelectronics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnoCare Optoelectronics Change In Receivables Chart

InnoCare Optoelectronics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial 159.34 -203.74 -17.79 -37.93 -114.85

InnoCare Optoelectronics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.43 -87.87 22.85 -117.95 123.33
TPE:6861
75GF Score
InnoCare Optoelectronics Corp TPE:6861
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InnoCare Optoelectronics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of NT$-60 Mil mean?
InnoCare Optoelectronics (TPE:6861) has a Change In Receivables of NT$-60 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for InnoCare Optoelectronics and its competitors.
Is InnoCare Optoelectronics' Change In Receivables too high?
InnoCare Optoelectronics' current Change In Receivables is NT$-60 Mil. Overall, InnoCare Optoelectronics has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' Change In Receivables compare to ABT and SYK?
InnoCare Optoelectronics' Change In Receivables of NT$-60 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for InnoCare Optoelectronics and its competitors. InnoCare Optoelectronics's current Change In Receivables is NT$-60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$101.54, compared to a current price of NT$186.50 — trading 83.7% above its estimated fair value. The current Change In Receivables is NT$-60 Mil. InnoCare Optoelectronics' overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current Change In Receivables is NT$-60 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?

Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued. The current stock price of NT$186.50 is trading 83.7% above its estimated GF Value™ of NT$101.54. GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.

Key valuation signals for TPE:6861:

  • Change In Receivables: NT$-60 Mil
  • GF Value™: NT$101.54 vs. price of NT$186.50 (83.7% above fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InnoCare Optoelectronics Business Description

Address Huanxi Road, Room B, No. 2, Section 2, Southern Science Park, Xincheng District, Tainan, TWN, 17571
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
75GF Score

Get the complete analysis for TPE:6861

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$186.50
Price
NT$101.54
GF Value